Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 13, 2019. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2019. Go to the latest filing (Q3 2026)

8.5B USDQ3 2019
Total value of stock positions
8.5B USD
Positions
30
Share of the ten largest
72.8%

The ten largest positions Q3 2019

  1. Liberty Global PLC 12.3%▲ +4.8%
  2. Viasat Inc 12.2%unchanged
  3. Fox Corporation (Class A) 10.1%unchanged
  4. eBay Inc. 7.6%▼ −31.1%
  5. Cheniere Energy Inc 7.5%▼ −5.0%
  6. Bristol Myers Squibb 6.0%▼ −23.1%
  7. Cbs Corp New 5.7%▲ +20.0%
  8. Qorvo Inc 5.0%▼ −34.6%
  9. Colony Cap Inc New 3.5%unchanged
  10. PG&E Corporation 2.9%unchanged
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q3 2019

Positions Q3 2019 per 13F filing, 11 of 11
Symbol Weight Shares Reported value Change Held since
Cheniere Energy Inc 7.5% 10,139,133 639.4M USD −5.0% reduced Q1 2014 23 quarters
Antero Res Corp 0.7% 21,087,791 63.7M USD −26.2% reduced Q3 2014 21 quarters
SYF Synchrony Financial 2.0% 5,003,981 170.6M USD −46.0% reduced Q3 2016 13 quarters
Trilogy Metals Inc New 0.2% 12,182,568 20.0M USD −10.7% reduced Q3 2016 13 quarters
Qorvo Inc 5.0% 5,681,181 421.2M USD −34.6% reduced Q1 2017 11 quarters
MCK McKesson Corporation 2.1% 1,306,011 178.5M USD −49.7% reduced Q3 2017 9 quarters
COR Cencora 1.1% 1,166,299 96.0M USD −47.3% reduced Q3 2017 9 quarters
EBAY eBay Inc. 7.6% 16,646,000 648.9M USD −31.1% reduced Q4 2018 4 quarters
BMY Bristol Myers Squibb 6.0% 10,000,000 507.1M USD −23.1% reduced Q1 2019 3 quarters
Takeda Pharmaceutical Co Ltd 1.9% 9,434,803 162.3M USD 0.0% reduced Q1 2019 3 quarters
Gossamer Bio Inc 0.2% 967,171 15.9M USD −23.7% reduced Q1 2019 3 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 2 positions in convertible bonds and bonds worth 331.1M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Tesla Inc principal 300.0M USD 303.5M USD
  • Theravance Biopharma Inc principal 30.0M USD 27.7M USD

Breakdown by sector

  • Communication Services 12.2%
  • Health Care 9.2%
  • Consumer Discretionary 7.6%
  • Utilities 2.9%
  • Financials 2.0%
  • not in our coverage 66.0%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close